Last Updated：2025/11/23
The vaccine candidate was antigenically similar to the circulating strain, prompting a robust neutralizing antibody response in early trials.
See correct answer
The vaccine candidate was antigenically similar to the circulating strain, prompting a robust neutralizing antibody response in early trials.
音声機能が動作しない場合はこちらをご確認ください
Edit Histories（0）
